GradePack

    • Home
    • Blog
Skip to content
bg
bg
bg
bg

GradePack

Which of the following is an appropriate strategy to incorpo…

Which of the following is an appropriate strategy to incorporate in attempting to overcome the barriers which can prevent the adoption of Evidence Based Practice in a healthcare facility?

Read Details

The model of diffusion used to incorporate Evidence Based Pr…

The model of diffusion used to incorporate Evidence Based Practice (EBP) incorporates which of the following four major concepts

Read Details

What will be the output of the following code? a = [[1, 2],…

What will be the output of the following code? a = [[1, 2], [3, 4]]b = a[:]b[0][0] = ‘changed’print(a)

Read Details

Choose all True statements.

Choose all True statements.

Read Details

A battery with EMF of 24 V and negligible internal resistanc…

A battery with EMF of 24 V and negligible internal resistance is connected to a resistor network as shown. Before the switch is closed, a current is delivered by the battery. After the switch is closed, a current is delivered by the battery. Find

Read Details

Geography is concerned with both the location of phenomena a…

Geography is concerned with both the location of phenomena and the reasons behind their distribution.

Read Details

Which of the following statements best describes static scop…

Which of the following statements best describes static scoping in Python?

Read Details

Bubble Sort is more efficient than Merge Sort for large data…

Bubble Sort is more efficient than Merge Sort for large datasets.

Read Details

A RCT compared eptinezumab (a new CGRP antagonist) to topira…

A RCT compared eptinezumab (a new CGRP antagonist) to topiramate for migraine prevention using an NI margin of 0.5 monthly migraine days. The mean decrease in monthly migraine days with eptinesumab was 3.9 days and with topiramate was 4.1 days (mean difference 0.2 days; 95%CI -0.02 to 0.42). Which of the following statements is the best interpretation of the results?

Read Details

Itepekimab was compared to placebo in a RCT for use in patie…

Itepekimab was compared to placebo in a RCT for use in patients with moderate-to-severe atopic dermatitis (i.e. severe skin inflammation and itching). The primary outcome was changes in the Eczema Area and Severity Index (EASI) score which has a minimally clinically important difference of a change in at least 6.6 points. At week 16 in the RCT, itepekimab had a mean decrease in the EASI score of 14.2 points compared to placebo (p=0.12).

Read Details

Posts pagination

Newer posts 1 … 37,727 37,728 37,729 37,730 37,731 … 90,140 Older posts

GradePack

  • Privacy Policy
  • Terms of Service
Top